Top compounds associated with response to FMO3


Feature Type Standardized
Nominal ANOVA
mRNA selumetinib:decitabine (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.059 0.07
mRNA JW-74 CTRPv2 pan-cancer AAC 0.079 0.08
mRNA NSC23766 CTRPv2 pan-cancer AAC 0.06 0.08
mRNA LFM-A13 GDSC1000 pan-cancer AAC -0.061 0.08
mRNA ZSTK474 GDSC1000 pan-cancer AAC 0.054 0.08
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.064 0.08
mRNA BYL-719 CTRPv2 pan-cancer AAC 0.074 0.08
mRNA R428 CTRPv2 pan-cancer AAC 0.073 0.08
mRNA Vorinostat gCSI pan-cancer AAC -0.09 0.08
mRNA VAF-347 CTRPv2 pan-cancer AAC 0.079 0.08
Download CSV